Bronchiolitis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Bronchiolitis}}
{{Bronchiolitis}}
Please help WikiDoc by adding content hereIt's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
 
==Overview==
The [[viral infection]] induces an [[inflammatory]] response which leads to infiltration of [[Inflamation#Celular component|inflammatory cells]] (RSV-specific lymphocytes), [[edema]] and [[necrosis]] of the [[epithelium]] in the [[bronchioles]] which is then sloughed into the lumina causing proliferation of cuboidal epithelial cells without cilia.<ref>{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref><ref name="pmid19209271">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271  }} </ref>  This phenomena leads to complete or partial obstruction due to reduction of the bronchiolar lumenina and necrotic tissue accumulation, leading to hyperinflation secondary to a valve mechanism produced by the obstruction of the airwayBy this mechanism, air can flow into the lungs by increased negastive pressure during inspiration but is unable to flow out of the lung as the airway's diameter is smaller during expiration.<ref>{{Cite book | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref> Obstructed areas can evolve to atelectasias. In childen Kohn channels are not well developed, therefore atelectasias and hyperinfletion can be greater.
 
Bronchiolitis is usually a self-limited infection which should be eliminated during the next 2 weeks after the infection in immunocompetent patients. However, dissemination of the virus in immunocompromised patients could remain for several months after initial infection.<ref name="pmid19209271">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271  }} </ref>
 
Some childre present recurrent episodes of wheezing after the initial RSV infection which has beed associated with the type of inflamatory response the patients presents during the initial disease.  In animal and, in less dimention, human models have shown that inflamation mediated Th2 cellular response is associated with increased production of IgE and proimmflamatory mediators present in athsma patients.<ref>{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref>  


==References==
==References==

Revision as of 16:38, 27 May 2014

Bronchiolitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiolitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Severity Score

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiolitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiolitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiolitis pathophysiology

CDC on Bronchiolitis pathophysiology

Bronchiolitis pathophysiology in the news

Blogs on Bronchiolitis pathophysiology

Directions to Hospitals Treating Bronchiolitis

Risk calculators and risk factors for Bronchiolitis pathophysiology

Overview

The viral infection induces an inflammatory response which leads to infiltration of inflammatory cells (RSV-specific lymphocytes), edema and necrosis of the epithelium in the bronchioles which is then sloughed into the lumina causing proliferation of cuboidal epithelial cells without cilia.[1][2] This phenomena leads to complete or partial obstruction due to reduction of the bronchiolar lumenina and necrotic tissue accumulation, leading to hyperinflation secondary to a valve mechanism produced by the obstruction of the airway. By this mechanism, air can flow into the lungs by increased negastive pressure during inspiration but is unable to flow out of the lung as the airway's diameter is smaller during expiration.[3] Obstructed areas can evolve to atelectasias. In childen Kohn channels are not well developed, therefore atelectasias and hyperinfletion can be greater.

Bronchiolitis is usually a self-limited infection which should be eliminated during the next 2 weeks after the infection in immunocompetent patients. However, dissemination of the virus in immunocompromised patients could remain for several months after initial infection.[2]

Some childre present recurrent episodes of wheezing after the initial RSV infection which has beed associated with the type of inflamatory response the patients presents during the initial disease. In animal and, in less dimention, human models have shown that inflamation mediated Th2 cellular response is associated with increased production of IgE and proimmflamatory mediators present in athsma patients.[4]

References

  1. Mandell, Gerald L.; Bennett, John E. (John Eugene); Dolin, Raphael. (2010). Mandell, Douglas, and Bennett's principles and practice of infectious disease. Philadelphia, PA: Churchill Livingstone/Elsevier.
  2. 2.0 2.1 Wright M, Mullett CJ, Piedimonte G (2008). "Pharmacological management of acute bronchiolitis". Ther Clin Risk Manag. 4 (5): 895–903. PMC 2621418. PMID 19209271.
  3. Mandell, Gerald L.; Bennett, John E. (John Eugene); Dolin, Raphael. (2010). Mandell, Douglas, and Bennett's principles and practice of infectious disease. Philadelphia, PA: Churchill Livingstone/Elsevier.
  4. Mandell, Gerald L.; Bennett, John E. (John Eugene); Dolin, Raphael. (2010). Mandell, Douglas, and Bennett's principles and practice of infectious disease. Philadelphia, PA: Churchill Livingstone/Elsevier.

Template:WH Template:WS